首頁 > 市場調查報告書 > 製藥

骨疾病

市場調查報告書

商品編碼

1672944

銀屑病乾癬治療市場按藥物類別、產品類型、給藥途徑、分銷管道和地區分類

Psoriatic Arthritis Treatment Market, By Drug Class, By Product Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年02月19日 | 出版商:

Coherent Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球乾癬性乾癬治療市場規模估計為 121.9 億美元，預計到 2032 年將達到 234.7 億美元，2025 年至 2032 年的複合年成長率為 9.8%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	121.9億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	9.80％	2032 年價值預測	234.7億美元

數字。 2025 年乾癬乾癬治療市場佔有率（按地區分類）

乾癬性關節炎是一種與乾癬同時發生的慢性發炎性關節炎。據估計，大約 30% 的乾癬患者會患上乾癬性關節炎。這種疾病會導致關節內和關節周圍疼痛、僵硬和腫脹。乾癬性關節炎隨著時間的推移會對關節造成永久性損傷。傳統治療方法包括使用胺基甲基葉酸和 TNF 抑制劑等緩解疾病的抗風濕藥物 (DMARD) 來控制症狀。全球銀屑病乾癬治療市場的成長得益於安全性和有效性更好的新型生物目標的不斷開發和核准。

市場動態：

全球銀屑病乾癬治療市場的成長是由全球銀屑病乾癬盛行率的增加所推動的。據估計，該疾病的全球盛行率為 0.06% 至 1%。此外，人們對疾病的認知不斷提高和先進治療方法的普及也推動了市場的成長。然而，生物製藥的高成本可能會阻礙市場成長，尤其是在價格敏感的新興市場。市場開發商持續努力開發具有成本效益的學名藥生物製藥可以逐漸降低成本。此外，新興經濟體醫療保健支出的增加可能會在不久的將來為市場參與者提供新的機會。

本研究的主要特點

本報告對全球乾癬性乾癬治療市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球銀屑病乾癬治療市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。

研究涉及的主要企業包括輝瑞、強生、艾伯維、諾華、UCB、禮來和百時美施貴寶。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、高階市場策略、市場擴張和行銷策略做出明智的決策。

全球銀屑病乾癬治療市場報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。

相關人員可以透過用於分析全球銀屑病乾癬治療市場的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 12.19 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.80%	2032 Value Projection:	USD 23.47 Bn

Psoriatic arthritis is a chronic inflammatory arthritis that occurs in conjunction with psoriasis. It is estimated that around 30% of people with psoriasis may develop psoriatic arthritis. The disease causes pain, stiffness and swelling in and around the joints. Over time, psoriatic arthritis can cause permanent damage to the joints. Conventional treatments including disease-modifying antirheumatic drugs (DMARDs) such as methotrexate and TNF inhibitors are used to manage the symptoms. Global psoriatic arthritis treatment market growth is driven by rising development and approval of novel targeted biologic therapies with better safety and efficacy profiles.

Market Dynamics:

Global psoriatic arthritis treatment market growth is driven by growing prevalence of psoriatic arthritis worldwide. According to estimates, the global prevalence of the disease ranges between 0.06% to 1%. Moreover, increasing awareness about the disease and availability of advanced treatments can also drive the market growth. However, high cost of biologic therapies can hamper the market growth, especially in price-sensitive developing regions. Continued efforts by market players to develop cost-effective generic versions of biologics can reduce costs over time. Furthermore, rising healthcare expenditures in emerging nations can offer new opportunities for the market players in the near future.

Key features of the study:

This report provides in-depth analysis of the global psoriatic arthritis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global psoriatic arthritis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Johnson & Johnson, AbbVie, Novartis, UCB, Eli Lilly, Bristol-Myers Squibb

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global psoriatic arthritis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global psoriatic arthritis treatment market

Detailed Segmentation-

Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Biologics
- Non-biologics
- Combination Therapy
Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Prescription
- Over-The-Counter (OTC)
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Parenteral
- Oral
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Medtronic
- Johnson & Johnson (DePuy Synthes)
- Zimmer Biomet
- Stryker
- Xtant Medical
- RTI Surgical
- SeaSpine
- Arthrex
- HansBioMed
- Exactech
- Wright Medical Group
- Bioventus
- Integra LifeSciences
- AlloSource
- Medline Industries
- Osiris Therapeutics
- Acelity
- Orthofix
- MTF Biologics
- Cerapedics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Psoriatic Arthritis Treatment Market, By Drug Class
- Global Psoriatic Arthritis Treatment Market, By Product Type
- Global Psoriatic Arthritis Treatment Market, By Route of Administration
- Global Psoriatic Arthritis Treatment Market, By Distribution Channel
- Global Psoriatic Arthritis Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Psoriatic Arthritis Treatment Market, By Drug Class, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Non-biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Combination Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Psoriatic Arthritis Treatment Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Prescription
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Over-The-Counter (OTC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Psoriatic Arthritis Treatment Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021- 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson (DePuy Synthes)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zimmer Biomet
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Stryker
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Xtant Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
RTI Surgical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SeaSpine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arthrex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HansBioMed
Exactech
Wright Medical Group
Bioventus
Integra LifeSciences
AlloSource
Medline Industries
Osiris Therapeutics
Acelity
Orthofix
MTF Biologics
Cerapedics

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

2024-2032 年按藥物類型（NSAID、DMARD、生物製劑等）、類型、給藥途徑、配銷通路和地區分類的銀屑病關節炎治療市場報告

乾癬性關節炎市場：KOL 洞察

乾癬性關節炎治療市場報告：2030 年趨勢、預測與競爭分析

FAQ

銀屑病乾癬治療市場按藥物類別、產品類型、給藥途徑、分銷管道和地區分類